Canada Life
APLT

Canada Life’s Applied Therapeutics APLT Stock Holding History

Canada Life’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,427
Closed -$8K – 1998
2024
Q4 		$8K Buy
+9,427
New +$59.1K ﹤0.01% 2018
2022
Q2 		– Sell
-997
Closed -$2K – 2431
2022
Q1 		$2K Hold
997
– – ﹤0.01% 2476
2021
Q4 		$9K Hold
997
– – ﹤0.01% 2453
2021
Q3 		$17K Hold
997
– – ﹤0.01% 2459
2021
Q2 		$21K Hold
997
– – ﹤0.01% 2472
2021
Q1 		$19K Hold
997
– – ﹤0.01% 2513
2020
Q4 		$22K Hold
997
– – ﹤0.01% 2519
2020
Q3 		$21K Hold
997
– – ﹤0.01% 2426
2020
Q2 		$36K Buy
+997
New +$41.7K ﹤0.01% 2335

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Canada Life's APLT Position: Q1 2025 in Review

Canada Life sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 9,427 shares — an estimated $8K sold.

Canada Life first reported a position in APLT in Q2 2020 and held it in 9 quarters. The position peaked at $36K in Q2 2020. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • Canada Life reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Canada Life sold 9,427 Applied Therapeutics shares in Q1 2025, an estimated $8K.
  • Canada Life first reported a position in Applied Therapeutics in Q2 2020 and held it in 9 quarters.
  • Canada Life's Applied Therapeutics position peaked at $36K in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Canada Life's 13F filing for Q1 2025, filed 15 May 2025.